PXN and prostate cancer: In the prostate cancer cell line PC-3 osteolytic model and the mixed osteolytic/osteogenic LNCaP model, paxillin knockdown resulted in reduced matrix adhesion and a general increase in cell invasion, but the opposite occurred in the MDA-MB-231 breast cancer model.